Sonoma Pharmaceuticals (SNOA) Enterprise Value (2010 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly Enterprise Value of -$2.4 million for Q1 2026, up 55.36% year-over-year from -$1.5 million in Q1 2025, and up 6.33% quarter-over-quarter from -$2.6 million in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Enterprise Value (2010 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Enterprise Value history runs 17 years deep, the most recent figure standing at -$2.4 million for Q1 2026.
- In Q1 2026, Enterprise Value rose 55.36% year-over-year to -$2.4 million; the TTM figure through Mar 2026 stood at -$2.4 million (up 55.36% YoY), while the FY2026 annual figure was -$2.4 million, up 55.36% from the prior year.
- Enterprise Value for Q1 2026 stood at -$2.4 million, up from -$2.6 million in the prior quarter.
- The five-year high for Enterprise Value was -$2.1 million in Q3 2023, with the low at -$7.4 million in Q1 2022.
- The 5-year median for Enterprise Value is -$3.4 million (2022), against an average of -$3.7 million.
- The sharpest annual moves came in 2022 and 2024: Enterprise Value surged 69.12% in 2022, then plunged 117.62% in 2024.
- Sonoma Pharmaceuticals' Enterprise Value stood at -$2.6 million in 2022, then increased by 8.66% to -$2.4 million in 2023, then tumbled by 117.62% to -$5.2 million in 2024, then jumped by 51.09% to -$2.6 million in 2025, then advanced by 6.33% to -$2.4 million in 2026.
- Business Quant data shows SNOA's Enterprise Value at -$2.4 million in Q1 2026, -$2.6 million in Q4 2025, and -$3.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | -164.00 Mn |
| 10 | Sonoma Pharmaceuticals | 5.17 Mn | -165,129.89 | 2.58 Mn | -5.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.34 Mn |
| Mar 31, 2026 | -2.40 Mn |
| Dec 31, 2025 | -2.56 Mn |
| Sep 30, 2025 | -3.04 Mn |
| Jun 30, 2025 | -3.61 Mn |
| Mar 31, 2025 | -5.37 Mn |
| Dec 31, 2024 | -5.24 Mn |
| Sep 30, 2024 | -4.08 Mn |
| Jun 30, 2024 | -2.59 Mn |
| Mar 31, 2024 | -3.13 Mn |
| Dec 31, 2023 | -2.41 Mn |
| Sep 30, 2023 | -2.14 Mn |
| Jun 30, 2023 | -3.54 Mn |
| Mar 31, 2023 | -3.82 Mn |
| Dec 31, 2022 | -2.63 Mn |
| Sep 30, 2022 | -3.35 Mn |
| Jun 30, 2022 | -5.59 Mn |
| Mar 31, 2022 | -7.40 Mn |
| Dec 31, 2021 | -8.53 Mn |
| Sep 30, 2021 | -8.39 Mn |